ArticleACS omega2022
Machine Learning Approach to Delineate the Impact of Material Properties on Solar Cell Device Physics.
Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Machine Learning in Non-fullerene Organic Solar Cells: Accelerating Discovery, Design, and Understanding.ACS omega · 2026Review
- Machine learning-enhanced novel design and performance optimization of MRSC advances · 2026Article
- Exploring optoelectronic and photovoltaic properties of BeScientific reports · 2026Article
- Computational optimization of MASnIRSC advances · 2026Article
- Simulated photovoltaic performance of N719 ruthenium dye sensitised solar cell with a power conversion efficiency exceeding 26% based on electron transport double layer.RSC advances · 2025Article
- Utilizing machine learning to enhance performance of thin-film solar cells based on SbRSC advances · 2024Article
- Mixed cations tin-germanium perovskite: A promising approach for enhanced solar cell applications.Heliyon · 2024Article
- Emerging BaZrSACS omega · 2024Article
- Meticulous research for design of plasmonics sensors for cancer detection and food contaminants analysis via machine learning and artificial intelligence.Scientific reports · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this research, solar cell capacitance simulator-one-dimensional (SCAPS-1D) software was used to build and probe nontoxic Cs-based perovskite solar devices and investigate modulations of key material parameters on ultimate power conversion efficiency (PCE). The input material parameters of the absorber Cs-perovskite layer were incrementally changed, and with the various resulting combinations, 63,500 unique devices were formed and probed to produce device PCE. Versatile and well-established machine learning algorithms were thereafter utilized to train, test, and evaluate the output dataset with a focused goal to delineate and rank the input material parameters for their impact on ultimate device performance and PCE. The most impactful parameters were then tuned to showcase unique ranges that would ultimately lead to higher device PCE values. As a validation step, the predicted results were confirmed against SCAPS simulated results as well, highlighting high accuracy and low error metrics. Further optimization of intrinsic material parameters was conducted through modulation of absorber layer thickness, back contact metal, and bulk defect concentration, resulting in an improvement in the PCE of the device from 13.29 to 16.68%. Overall, the results from this investigation provide much-needed insight and guidance for researchers at large, and experimentalists in particular, toward fabricating commercially viable nontoxic inorganic perovskite alternatives for the burgeoning solar industry.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.